Article info

Download PDFPDF

New emerging targets in cancer immunotherapy: the role of neoantigens

Authors

  • Leticia De Mattos-Arruda IrsiCaixa AIDS Research Institute, Germans Trias i Pujol University Hospital, Badalona, SpainGermans Trias i Pujol Research Institute (IGTP), Badalona, Spain PubMed articlesGoogle scholar articles
  • Juan Blanco-Heredia IrsiCaixa AIDS Research Institute, Germans Trias i Pujol University Hospital, Badalona, SpainGermans Trias i Pujol Research Institute (IGTP), Badalona, Spain PubMed articlesGoogle scholar articles
  • Carmen Aguilar-Gurrieri IrsiCaixa AIDS Research Institute, Germans Trias i Pujol University Hospital, Badalona, Spain PubMed articlesGoogle scholar articles
  • Jorge Carrillo IrsiCaixa AIDS Research Institute, Germans Trias i Pujol University Hospital, Badalona, SpainGermans Trias i Pujol Research Institute (IGTP), Badalona, Spain PubMed articlesGoogle scholar articles
  • Julià Blanco IrsiCaixa AIDS Research Institute, Germans Trias i Pujol University Hospital, Badalona, SpainGermans Trias i Pujol Research Institute (IGTP), Badalona, SpainUniversitat de Vic-Universitat Central de Catalunya (UVic-UCC), Vic, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Leticia De Mattos-Arruda; ldemattos{at}irsicaixa.es
View Full Text

Citation

De Mattos-Arruda L, Blanco-Heredia J, Aguilar-Gurrieri C, et al
New emerging targets in cancer immunotherapy: the role of neoantigens

Publication history

  • Received January 15, 2020
  • Revised February 19, 2020
  • Accepted February 20, 2020
  • First published April 8, 2020.
Online issue publication 
April 08, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.